Syngene International Limited (NSE:SYNGENE)
India · Delayed Price · Currency is INR 664.30
+8.65 (1.32%)
Jan 7, 2026, 11:50 AM IST
Syngene International Market Cap
Syngene International has a market cap or net worth of 261.01 billion as of January 6, 2026. Its market cap has decreased by -23.64% in one year.
Market Cap
261.01B
Enterprise Value
255.92B
Revenue
37.47B
Ranking
n/a
PE Ratio
60.06
Stock Price
664.30
Market Cap Chart
Since August 11, 2015, Syngene International's market cap has increased from 62.11B to 261.01B, an increase of 320.24%. That is a compound annual growth rate of 14.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 261.01B | 0.71% |
| Dec 31, 2025 | 259.16B | -24.09% |
| Dec 31, 2024 | 341.40B | 22.54% |
| Dec 29, 2023 | 278.60B | 19.79% |
| Dec 30, 2022 | 232.57B | -5.39% |
| Dec 31, 2021 | 245.81B | -3.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.22T |
| Divi's Laboratories | 1.76T |
| Cipla | 1.24T |
| Apollo Hospitals Enterprise | 1.06T |
| Zydus Lifesciences | 936.85B |
| Mankind Pharma | 925.01B |
| Aurobindo Pharma | 715.14B |
| Fortis Healthcare | 713.44B |